nafenopin has been researched along with Hyperplasia in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 5 (71.43) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
James, NH; Roberts, RA | 1 |
Columbano, A; Coni, P; de Prati, AC; Ledda-Columbano, GM; Menegazzi, M; Sarma, DS; Simbula, G; Suzuki, H | 1 |
Columbano, A; Katyal, SL; Ledda-Columbano, GM; Ohmura, T; Shinozuka, H; Zedda, AI | 1 |
Carcereri-De Prati, A; Columbano, A; Ledda-Columbano, GM; Menegazzi, M; Pibiri, M; Piga, R; Shinozuka, H; Suzuki, H | 1 |
Moody, DE; Rao, MS; Reddy, JK | 1 |
Chelo, A; Columbano, A; Curto, M; Ennas, MG; Ledda-Columbano, GM; Pani, P | 1 |
Bursch, W; Düsterberg, B; Schulte-Hermann, R | 1 |
7 other study(ies) available for nafenopin and Hyperplasia
Article | Year |
---|---|
The peroxisome proliferator class of non-genotoxic hepatocarcinogens synergize with epidermal growth factor to promote clonal expansion of initiated rat hepatocytes.
Topics: Albumins; Animals; Biomarkers; Carcinogens; Cell Division; Cell Transformation, Neoplastic; Cells, Cultured; Clone Cells; Cocarcinogenesis; Colony-Forming Units Assay; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; DNA Replication; Drug Synergism; Epidermal Growth Factor; Hyperplasia; Liver; Liver Neoplasms, Experimental; Male; Microbodies; Mixed Function Oxygenases; Nafenopin; Rats; Rats, Wistar; Transforming Growth Factor alpha | 1994 |
Differences in the steady-state levels of c-fos, c-jun and c-myc messenger RNA during mitogen-induced liver growth and compensatory regeneration.
Topics: Animals; Carbon Tetrachloride; Cell Division; Cyproterone Acetate; Ethylene Dibromide; Gene Expression; Genes, fos; Genes, jun; Genes, myc; Hepatectomy; Hyperplasia; Lead; Liver; Liver Regeneration; Male; Nafenopin; Nitrates; Rats; Rats, Wistar; RNA, Messenger | 1993 |
Possible roles of nonparenchymal cells in hepatocyte proliferation induced by lead nitrate and by tumor necrosis factor alpha.
Topics: Animals; Bromodeoxyuridine; Cell Division; DNA; Humans; Hyperplasia; Immunohistochemistry; Lead; Liver; Male; Mitogens; Nafenopin; Nitrates; Rats; Rats, Wistar; Recombinant Proteins; RNA, Messenger; Tumor Necrosis Factor-alpha | 1996 |
Liver cell proliferation induced by nafenopin and cyproterone acetate is not associated with increases in activation of transcription factors NF-kappaB and AP-1 or with expression of tumor necrosis factor alpha.
Topics: Animals; Binding, Competitive; Carbon Tetrachloride; Cell Division; Cyproterone Acetate; Hepatectomy; Hyperplasia; Lead; Liver; Liver Regeneration; Male; Mitogens; Nafenopin; NF-kappa B; Nitrates; Rats; Rats, Wistar; RNA, Messenger; Transcription Factor AP-1; Tumor Necrosis Factor-alpha | 1997 |
Mitogenic effect in mouse liver induced by a hypolipidemic drug, nafenopin.
Topics: Animals; Hyperplasia; Hypertrophy; Liver; Male; Mice; Mice, Inbred Strains; Microbodies; Mitogens; Nafenopin; Propionates | 1977 |
Cell proliferation and promotion of rat liver carcinogenesis: different effect of hepatic regeneration and mitogen induced hyperplasia on the development of enzyme-altered foci.
Topics: Adenosine Triphosphatases; Animals; Body Weight; Carbon Tetrachloride; Cell Division; Diethylnitrosamine; Ethylene Dibromide; gamma-Glutamyltransferase; Hyperplasia; Lead; Liver; Liver Neoplasms; Male; Nafenopin; Nitrates; Propionates; Rats; Rats, Inbred Strains | 1990 |
Growth, regression and cell death in rat liver as related to tissue levels of the hepatomitogen cyproterone acetate.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Cell Survival; Cyproterone; Cyproterone Acetate; DNA; Female; Hexachlorocyclohexane; Hyperplasia; Kinetics; Liver; Nafenopin; Rats; Rats, Inbred Strains | 1986 |